Page last updated: 2024-11-03

practolol and Obesity

practolol has been researched along with Obesity in 1 studies

Practolol: A beta-1 adrenergic antagonist that has been used in the emergency treatment of CARDIAC ARRYTHMIAS.
practolol : N-(4-Hydroxyphenyl)acetamide in which the hydrogen of the phenolic hydroxy group is substituted by a 3-(isopropylaminoamino)-2-hydroxypropyl group. A selective beta blocker, it has been used in the emergency treatment of cardiac arrhythmias.

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lotti, G1
Delitala, G1
Masala, A1

Other Studies

1 other study available for practolol and Obesity

ArticleYear
Letter: Enhancement of levodopa-induced growth-hormone stimulation by practolol.
    Lancet (London, England), 1974, Nov-30, Volume: 2, Issue:7892

    Topics: Drug Synergism; Growth Hormone; Humans; Levodopa; Obesity; Practolol; Propranolol; Stimulation, Chem

1974